ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas

Name: ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas
License: Public Domain

Peking University People's Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

adenocarcinoma of lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226237
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.